These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9437539)

  • 1. Comparison of three serum assays for bone collagen formation during postmenopausal estrogen-progestin therapy.
    Suvanto-Luukkonen E; Risteli L; Sundström H; Penttinen J; Kauppila A; Risteli J
    Clin Chim Acta; 1997 Oct; 266(2):105-16. PubMed ID: 9437539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of low- and conventional-dose transcutaneous HRT over 2 years on bone metabolism in younger and older postmenopausal women.
    Sharp CA; Evans SF; Risteli L; Risteli J; Worsfold M; Davie MW
    Eur J Clin Invest; 1996 Sep; 26(9):763-71. PubMed ID: 8889438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.
    Peris P; Alvarez L; Monegal A; Guañabens N; Durán M; Pons F; Martínez de Osaba MJ; Echevarría M; Ballesta AM; Muñoz-Gómez J
    Bone; 1999 Sep; 25(3):349-53. PubMed ID: 10495139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuously combined hormone replacement therapy and bone turnover: the influence of dydrogesterone dose, smoking and initial degree of bone turnover.
    de Valk-de Roo GW; Netelenbos JC; Peters-Muller IR; Voetberg GA; van de Weijer PH; Bouman AA; Popp-Snijders C; Kenemans P
    Maturitas; 1997 Dec; 28(2):153-62. PubMed ID: 9522323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.
    Tähtelä R; Thölix E
    Anticancer Res; 1996; 16(4B):2289-93. PubMed ID: 8694558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Episodic changes of serum procollagen type I carboxy-terminal propeptide levels in fertile and postmenopausal women.
    Sgherzi MR; Fabbri G; Bonati M; Maietta Latessa A; Segre A; De Vita D; De Leo V; Genazzani AD; Petraglia F; Genazzani AR
    Gynecol Obstet Invest; 1994; 38(1):60-4. PubMed ID: 7959331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference between total and intact assays for N-terminal propeptide of type I procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide.
    Koivula MK; Ruotsalainen V; Björkman M; Nurmenniemi S; Ikäheimo R; Savolainen K; Sorva A; Risteli J
    Ann Clin Biochem; 2010 Jan; 47(Pt 1):67-71. PubMed ID: 19940208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low synthesis rate of type I procollagen is normalized during active back rehabilitation.
    Hupli M; Hurri H; Luoto S; Risteli L; Vanharanta H; Risteli J
    Spine (Phila Pa 1976); 1997 Apr; 22(8):850-4. PubMed ID: 9127916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.
    Hannon R; Blumsohn A; Naylor K; Eastell R
    J Bone Miner Res; 1998 Jul; 13(7):1124-33. PubMed ID: 9661076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of micronized progesterone on bone turnover in postmenopausal women on estrogen replacement therapy.
    Azizi G; Hansen A; Prestwood KM
    Endocr Res; 2003 May; 29(2):133-40. PubMed ID: 12856800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases.
    Ebeling PR; Peterson JM; Riggs BL
    J Bone Miner Res; 1992 Nov; 7(11):1243-50. PubMed ID: 1466250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of inhaled beclomethasone on serum markers of collagen metabolism in postmenopausal asthmatic women.
    Puolijoki H; Risteli J; Herrala J; Risteli L; Liippo K
    Respir Med; 1996 Jul; 90(6):339-42. PubMed ID: 8759476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum.
    Koivula MK; Risteli L; Risteli J
    Clin Biochem; 2012 Aug; 45(12):920-7. PubMed ID: 22480789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
    Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
    Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procollagen assays in cancer.
    Risteli L; Koivula MK; Risteli J
    Adv Clin Chem; 2014; 66():79-100. PubMed ID: 25344986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepant expression of carboxy- and aminoterminal propeptides of type I procollagen predicts poor clinical outcome in epithelial ovarian cancer.
    Simojoki M; Santala M; Risteli J; Kauppila A
    Gynecol Oncol; 2003 Mar; 88(3):358-62. PubMed ID: 12648587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
    Lin DY; Chu CM; Sheen IS; Liaw YF
    Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive breast cancer leads to discrepant serum levels of the type I procollagen propeptides PINP and PICP.
    Jukkola A; Tähtelä R; Thölix E; Vuorinen K; Blanco G; Risteli L; Risteli J
    Cancer Res; 1997 Dec; 57(24):5517-20. PubMed ID: 9407961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers of bone formation in the study of postmenopausal osteoporosis.
    Dominguez Cabrera C; Sosa Henríquez M; Traba ML; Alvarez Villafañe E; de la Piedra C
    Osteoporos Int; 1998; 8(2):147-51. PubMed ID: 9666938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.